UK markets closed

Cyteir Therapeutics, Inc. (CYT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.61+0.77 (+5.56%)
As of 12:52PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close13.84
Open13.67
Bid14.40 x 1000
Ask14.56 x 900
Day's range13.67 - 14.61
52-week range13.67 - 23.10
Volume14,931
Avg. volume115,358
Market cap516.769M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-3.20
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est31.50
  • Business Wire

    Cyteir Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights

    LEXINGTON, Mass., November 12, 2021--Cyteir Therapeutics, Inc. ("Cyteir") (Nasdaq: CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, today reported financial results for the third quarter ended September 30, 2021 and provided an update on recent business highlights.

  • Business Wire

    Cyteir Therapeutics to Participate in the Credit Suisse 30th Annual Healthcare Conference

    LEXINGTON, Mass., November 01, 2021--Cyteir Therapeutics, Inc. ("Cyteir") (Nasdaq: CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, announced that its President and Chief Executive Officer Markus Renschler, MD will participate in a presentation at the Credit Suisse 30th Annual Healthcare Conference, being held virtually on November 8, 2021, at 4:20pm ET.

  • Business Wire

    Cyteir Therapeutics Selected to Join Russell 2000® Index

    LEXINGTON, Mass., September 20, 2021--Cyteir Therapeutics, Inc. ("Cyteir") (Nasdaq: CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer was added as a member of the U.S. small-cap Russell 2000® Index, effective after the US market opens on September 20, as part of the 2021 Russell indexes reconstitution. Membership in the Russell 2000® Index, which remains in place for one year, is based on membership in the broad-market Russell 3